In summary, these results shed light on the important role of lncRNA NORAD in AMD development and progression (Figure 7) and provide a foundation for developing more targeted AMD therapies and predicting whether low NORAD expression is likely linked to the development of AMD or other diseases of aging. The gene discussed is NORAD; the disease is age-related macular degeneration.